Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil

被引:35
|
作者
Oliveira-Santos, M. [1 ,2 ]
Verani, J. F. S. [1 ]
Klumb, E. M. [2 ]
Albuquerque, E. M. N. [2 ]
机构
[1] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos Saude, Rio De Janeiro, Brazil
[2] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil
关键词
adherence to drug treatment; systemic lupus erythematosus; hierarchical multivariate analysis; RECOMMENDATIONS; MEDICATIONS; AMERICAN;
D O I
10.1177/0961203310383736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objectives of this study were to measure the prevalence of adherence to drug treatment and analyze associations with characteristics pertaining to the treatment, disease, health professionals and services, and socio-demographic issues in patients with systemic lupus erythematosus (SLE) in the city of Rio de Janeiro, Brazil. A sample of 246 women with SLE was analyzed. The data were collected through individual interviews and a review of patient charts. Adherence was estimated according to the Morisk criteria, and the associated factors were analyzed by hierarchical modeling. The percentage of patients classified as adherent to treatment was 31.7%. The reasons cited for non-adherence were: carelessness with drug administration times (52.43%), forgetfulness (38.21%), adverse drug reaction (13.8%), and interruption of treatment due to improvement in symptoms (7.72%). Factors associated with adherence were: behavior towards the presence of adverse drug reaction, hematological alterations, presence of mucocutaneous manifestations, legibility of the medical prescription, schooling, and family support. The study concludes that adherence to drug treatment in SLE is a complex and multifactorial phenomenon, and the results corroborate findings from studies conducted in developed countries. The hierarchical modeling proved to be a good alternative for evaluating adherence, since it allowed visualizing the various stages in the analysis. Lupus (2011) 20, 320-329.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [1] Adherence to treatment in systemic lupus erythematosus patients
    Costedoat-Chalumeau, Nathalie
    Pouchot, Jacques
    Guettrot-Imbert, Gaelle
    Le Guern, Veronique
    Leroux, Gaelle
    Marra, Donata
    Morel, Nathalie
    Piette, Jean-Charles
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2013, 27 (03): : 329 - 340
  • [2] Adherence to treatment in patients with systemic lupus erythematosus
    Prados-Moreno, Sebastian
    Mario Sabio, Jose
    Manuel Perez-Marmol, Jose
    Navarrete-Navarrete, Nuria
    Isabel Peralta-Ramirez, Maria
    MEDICINA CLINICA, 2018, 150 (01): : 8 - 15
  • [3] DRUG ADHERENCE IMPACT ON SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS HEALTH
    El-Azizi, N. O.
    Elhefny, A. A. M.
    El-Rahman, M. A. Adb
    Abou-Sheashaa, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 420 - 420
  • [4] Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in Brazil
    Prudente, Luciana Resende
    Diniz, Juliana de Souza
    Almeida Matteucci Ferreira, Tatyana Xavier
    Lima, Dione Marcal
    Silva, Nilzio Antonio
    Saraiva, Guylherme
    Silveira, Erika Aparecida
    Souza Dewulf, Nathalie de Lourdes
    Amaral, Rita Goreti
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 863 - 870
  • [5] Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus
    Araceli Garcia-Gonzalez
    Marsha Richardson
    Maria Garcia Popa-Lisseanu
    Vanessa Cox
    Michael A. Kallen
    Namieta Janssen
    Bernard Ng
    Donald M. Marcus
    John D. Reveille
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2008, 27 : 883 - 889
  • [6] Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus
    Garcia-Gonzalez, Araceli
    Richardson, Marsha
    Popa-Lisseanu, Maria Garcia
    Cox, Vanessa
    Kallen, Michael A.
    Janssen, Namieta
    Ng, Bernard
    Marcus, Donald M.
    Reveille, John D.
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 883 - 889
  • [7] Treatment adherence in systemic lupus erythematosus (SLE)
    McElhone, K
    Teh, LS
    Walker, J
    Abbott, J
    RHEUMATOLOGY, 2005, 44 : I141 - I141
  • [8] Adherence to Treatment and Social, Educational Levels in Patients with Systemic Lupus Erythematosus
    Sueldo, Raul
    Constanza Bertolaccini, Maria
    Maldonado, Ramiro
    Romero, Julia
    Gonzalez Lucero, Luciana
    Machado Escobar, Maximiliano
    Galindo, Liliana
    Santana, Mirta
    Lucero, Eleonora
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Treatment adherence and clinical outcome in systemic lupus erythematosus
    Chambers, S. A.
    Rahman, A.
    Isenberg, D. A.
    RHEUMATOLOGY, 2007, 46 (06) : 895 - 898
  • [10] EVALUATION OF THE IMPACT OF ROUTINE MONITORING OF BLOOD HYDROXYCHLOROQUINE LEVELS ON ADHERENCE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Tamirou, Farah
    Chasset, Francois
    Le Guern, Veronique
    Blanchet, Benoit
    Le Jeunne, Claire
    Costedoat-Chalumeau, Nathalie
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 784 - 785